Wolverine Asset Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,000
Closed -$33K 2509
2022
Q2
$33K Hold
1,000
﹤0.01% 1693
2022
Q1
$72K Hold
1,000
﹤0.01% 1403
2021
Q4
$91K Hold
1,000
﹤0.01% 1386
2021
Q3
$126K Hold
1,000
﹤0.01% 1251
2021
Q2
$166K Hold
1,000
﹤0.01% 1317
2021
Q1
$181K Sell
1,000
-32,000
-97% -$7.42M ﹤0.01% 1266
2020
Q4
$6.6M Buy
+33,000
New +$6.71M 0.05% 225
2019
Q1
Sell
-57,300
Closed -$2.84M 1687
2018
Q4
$2.84M Buy
+57,300
New +$3.51M 0.03% 435
2018
Q3
Sell
-5,700
Closed -$330K 1634
2018
Q2
$330K Hold
5,700
﹤0.01% 1020
2018
Q1
$229K Buy
+5,700
New +$215K ﹤0.01% 1128

Other funds holding TDOC

Wolverine Asset Management's TDOC Position: Q1 2023 in Review

Wolverine Asset Management sold out of Teladoc Health (TDOC) in Q1 2023, closing a stake of 2 shares — an estimated $47 sold.

Wolverine Asset Management first reported a position in TDOC in Q1 2018 and held it in 10 quarters. The position peaked at $2.24M in Q2 2019. 429 funds tracked by Wall St. Rank hold TDOC as of Q1 2023.

  • Wolverine Asset Management reported no remaining Teladoc Health position as of Q1 2023 after selling out during the quarter.
  • Wolverine Asset Management sold 2 Teladoc Health shares in Q1 2023, an estimated $47.
  • Wolverine Asset Management first reported a position in Teladoc Health in Q1 2018 and held it in 10 quarters.
  • Wolverine Asset Management's Teladoc Health position peaked at $2.24M in Q2 2019.
  • 429 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2023.

Based on Wolverine Asset Management's 13F filing for Q1 2023, filed 8 May 2023.